Updating clinical guidelines

Rated 3.94/5 based on 910 customer reviews

ACP recommends that clinicians offer pharmacologic treatment with alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk for hip and vertebral fractures in women who have known osteoporosis.

updating clinical guidelines-66

updating clinical guidelines-6

(symptomatic pregnant women) are the same, regardless of their level of exposure (i.e., women with ongoing risk for possible exposure, including residence in or frequent travel to an area with active Zika virus transmission, as well as women living in areas without Zika virus transmission who travel to an area with active Zika virus transmission, or have unprotected sex with a partner who traveled to or resides in an area with active Zika virus transmission).The NCCN Guidelines currently apply to more than 97% of patients living with cancer in the United States.The NCCN Guidelines incorporate real-time updates in keeping with the rapid advancements in the field of cancer research and management.Specific NCCN Guidelines have also been developed for cancer screening and prevention, as well as for supportive care issues important to the management of patients with cancer.The NCCN Guidelines are intended to assist all individuals who impact the decision making in cancer care including physicians, nurses, pharmacists, payers, patients and their families, and many others.

Leave a Reply